tetrahydrocannabivarin
Small moleculeexperimental
Clinical trial activity
4 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2010 (NCT01217112)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
CCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21- Mol. weight
- 286.42 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2387541 ↗
Also known as
- gwp42004
- tetrahydrocannabivarin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05574049 | Early Phase 1 (Phase 1) | Jan 4, 2022 | Medical Life Care Planners, LLC |
| NCT02053272 | Phase 2 | Feb 1, 2014 | GW Research, University of Leicester |
| NCT01491490 | Phase 2 | Oct 1, 2011 | GW Research |
| NCT01217112 | Phase 2 | Oct 1, 2010 | GW Research, MAC UK Neuroscience Ltd, Mount Farm Surgery, Suffolk, University of East Anglia, University of Nottingham, Woolpit Health Centre |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GW Research | For profit | 3 | 3 | 1 | 2010 |
| MAC UK Neuroscience Ltd | For profit | 1 | 0 | 1 | 2010 |
| Medical Life Care Planners, LLC | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Mount Farm Surgery, Suffolk | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of East Anglia | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Leicester | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Nottingham | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Woolpit Health Centre | Academic/Hospital | 1 | 0 | 1 | 2010 |
8 organizations
Page 1 / 1